Multiple Sclerosis: Difference between revisions

From The School of Biomedical Sciences Wiki
Jump to navigation Jump to search
No edit summary
Nnjm2 (talk | contribs)
Fixed a number of issues with the formatting. Fixed a problem with the references.
 
(5 intermediate revisions by 4 users not shown)
Line 1: Line 1:
<u>'''WHAT&nbsp;IS&nbsp;MULTIPLE&nbsp;SCLEROSIS'''</u><br>Multiple Sclerosis (abbreviated MS) is an autoimmune disease first diagnosed in 1849, which essentially doesn’t have a cure. It is an example of a chronic autoimmune disease, during which the patient's own [[Immune_system|immune system]] attacks the healthy cells of the brain and the spinal cord (the two components of the [[Central_nervous_system|CNS]]). MS targets [[Neuron|neurons]] that are responsible for the creation of thoughts, sense perception, and the communication between the different parts of the body. It occurs due to demyelination of the fatty [[Myelin_Sheath|myelin sheath ]]that surrounds [[Axon|axons]] in nerve cells. This leads to the loss of communication between nerve cells.<br>
=== What is Multiple Sclerosis?  ===


Multiple Sclerosis (abbreviated MS) is an [[Autoimmune disease|autoimmune disease]]&nbsp;which affects around 100,000 people <ref>http://www.nhs.uk/Conditions/Multiple-sclerosis/Pages/Introduction.aspx</ref>&nbsp;in the UK, it was first diagnosed in 1849, which essentially doesn’t have a cure. It is an example of a chronic autoimmune disease, during which the patient's own [[Immune system|immune system]]&nbsp;mistakes myelin for a foreign body and&nbsp;attacks the cells. MS targets [[Neuron|neurons]] that are responsible for the creation of thoughts, sense perception, and the communication between the different parts of the body. It occurs due to demyelination of the fatty [[Myelin Sheath|myelin sheath that]] surrounds [[Axon|axons]] in nerve cells. This demyelination prevents the propogation of action potentials between the [[Nodes of Ranvier]]&nbsp;this essentially&nbsp;leads to the loss of communication between nerve cells and results in the loss of muscle function giving symptoms such as vision, balance and bladder issues.&nbsp;<ref>http://www.mssociety.org.uk/what-is-ms/signs-and-symptoms</ref>


=== Physical Symptoms<br>  ===


<u>'''PHYSICAL&nbsp;SYMPTOMS'''</u><br>
*Changes in sensation
*[[Muscle|Muscle]] weakness<br>  
*Abnormal muscle spasmps<br>  
*Difficulty with movement or balance<br>
*Difficulty with speech<br>
*Difficulty with vision<br>


*Changes in sensation<br>
Approximately 2.5 million people worldwide have MS. “MS is twice as common in females as it is in males, and it is usually diagnosed between the age of 20 and 40, however there have been cases where MS has been found in children and in the elderly” <ref>Multiple sclerosis” Psychology Wiki</ref>.<br>  
*[[Muscle|Muscle]] weakness<br>
 
*Abnormal muscle spasmps<br>
"Restrictions in mobility (walking, transfers, bed mobility etc.) are common in individuals suffering from multiple sclerosis. Within 10 years after the onset of MS one-third of patients reach a score of 6 on the Expanded Disability Status Scale (EDSS), requiring the use of a unilateral walking aid, and by 30 years the proportion increases to 83%. Within five years of onset the EDSS is six in 50% of those with the progressive form of MS." <ref>Weinshenker BG, Bass B, Rice GP, et al. (1989). "The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability". Brain 112 (1): 133–46.</ref>  
*Difficulty with movement or balance<br>
 
*Difficulty with speech<br>
=== Cognitive Symptoms  ===
*Difficulty with vision<br>
 
*Loss of memory recall
*Loss of attention


<br>
Studies have shown that up to 50 to 66% of multiple sclerosis patients will experience some form of cognitive dysfunction&nbsp;<ref>Rosalind et al. 138</ref><br>  


Approximately 2.5 million people worldwide have MS. “MS is twice as common in females as it is in males, and it is usually diagnosed between the age of 20 and 40, however there have been cases where MS has been found in children and in the elderly” ("Multiple sclerosis” Psychology Wiki).<br>
=== Treatment  ===


<br>
Treatment for a relapse usually involves either:


<u>'''COGNITIVE&nbsp;SYMPTOMS'''</u><br>
*a five-day course of steroid tablets taken at home
*injections of steroid medication given in hospital for three to five days


*Loss of memory recall<br>
Steroids can help speed up your recovery from a relapse, but they don't prevent further relapses or stop MS getting worse over time.
*Loss of attention<br>


Studies have shown that up to 50 to 66% of multiple sclerosis patients will experience some form of cognitive dysfunction (Rosalind et al. 138)<br>
They are only given for a short period of time to avoid possible steroid side effects, such as osteoporosis (weak bones), weight gain and diabetes, although some people will still experience problems.  


Not using steroids more than three times a year (if possible) will also help to reduce the risk of side effects&nbsp;<ref>http://www.nhs.uk/Conditions/Multiple-sclerosis/Pages/Treatment.aspx</ref>.<br>


=== References  ===


<br>
<references />

Latest revision as of 20:48, 20 October 2016

What is Multiple Sclerosis?

Multiple Sclerosis (abbreviated MS) is an autoimmune disease which affects around 100,000 people [1] in the UK, it was first diagnosed in 1849, which essentially doesn’t have a cure. It is an example of a chronic autoimmune disease, during which the patient's own immune system mistakes myelin for a foreign body and attacks the cells. MS targets neurons that are responsible for the creation of thoughts, sense perception, and the communication between the different parts of the body. It occurs due to demyelination of the fatty myelin sheath that surrounds axons in nerve cells. This demyelination prevents the propogation of action potentials between the Nodes of Ranvier this essentially leads to the loss of communication between nerve cells and results in the loss of muscle function giving symptoms such as vision, balance and bladder issues. [2]

Physical Symptoms

  • Changes in sensation
  • Muscle weakness
  • Abnormal muscle spasmps
  • Difficulty with movement or balance
  • Difficulty with speech
  • Difficulty with vision

Approximately 2.5 million people worldwide have MS. “MS is twice as common in females as it is in males, and it is usually diagnosed between the age of 20 and 40, however there have been cases where MS has been found in children and in the elderly” [3].

"Restrictions in mobility (walking, transfers, bed mobility etc.) are common in individuals suffering from multiple sclerosis. Within 10 years after the onset of MS one-third of patients reach a score of 6 on the Expanded Disability Status Scale (EDSS), requiring the use of a unilateral walking aid, and by 30 years the proportion increases to 83%. Within five years of onset the EDSS is six in 50% of those with the progressive form of MS." [4]

Cognitive Symptoms

  • Loss of memory recall
  • Loss of attention

Studies have shown that up to 50 to 66% of multiple sclerosis patients will experience some form of cognitive dysfunction [5]

Treatment

Treatment for a relapse usually involves either:

  • a five-day course of steroid tablets taken at home
  • injections of steroid medication given in hospital for three to five days

Steroids can help speed up your recovery from a relapse, but they don't prevent further relapses or stop MS getting worse over time.

They are only given for a short period of time to avoid possible steroid side effects, such as osteoporosis (weak bones), weight gain and diabetes, although some people will still experience problems.

Not using steroids more than three times a year (if possible) will also help to reduce the risk of side effects [6].

References

  1. http://www.nhs.uk/Conditions/Multiple-sclerosis/Pages/Introduction.aspx
  2. http://www.mssociety.org.uk/what-is-ms/signs-and-symptoms
  3. Multiple sclerosis” Psychology Wiki
  4. Weinshenker BG, Bass B, Rice GP, et al. (1989). "The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability". Brain 112 (1): 133–46.
  5. Rosalind et al. 138
  6. http://www.nhs.uk/Conditions/Multiple-sclerosis/Pages/Treatment.aspx